- Home
- NVAX vs JBLU Comparison
NVAX vs JBLU Comparison
Compare NVAX & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- JBLU
- Stock Information
- Founded
- NVAX 1987
- JBLU 1998
- Country
- NVAX United States
- JBLU United States
- Employees
- NVAX N/A
- JBLU N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- JBLU Air Freight/Delivery Services
- Sector
- NVAX Health Care
- JBLU Consumer Discretionary
- Exchange
- NVAX Nasdaq
- JBLU Nasdaq
- Market Cap
- NVAX 2.0B
- JBLU 2.0B
- IPO Year
- NVAX 1995
- JBLU N/A
- Fundamental
- Price
- NVAX $9.76
- JBLU $5.67
- Analyst Decision
- NVAX Buy
- JBLU Hold
- Analyst Count
- NVAX 6
- JBLU 10
- Target Price
- NVAX $17.83
- JBLU $6.31
- AVG Volume (30 Days)
- NVAX 7.2M
- JBLU 17.0M
- Earning Date
- NVAX 11-07-2024
- JBLU 10-29-2024
- Dividend Yield
- NVAX N/A
- JBLU N/A
- EPS Growth
- NVAX N/A
- JBLU N/A
- EPS
- NVAX N/A
- JBLU N/A
- Revenue
- NVAX $987,667,000.00
- JBLU $9,327,000,000.00
- Revenue This Year
- NVAX N/A
- JBLU N/A
- Revenue Next Year
- NVAX N/A
- JBLU $4.68
- P/E Ratio
- NVAX N/A
- JBLU N/A
- Revenue Growth
- NVAX N/A
- JBLU N/A
- 52 Week Low
- NVAX $3.53
- JBLU $3.42
- 52 Week High
- NVAX $23.86
- JBLU $8.07
- Technical
- Relative Strength Index (RSI)
- NVAX 36.20
- JBLU 38.78
- Support Level
- NVAX $9.52
- JBLU $6.86
- Resistance Level
- NVAX $10.63
- JBLU $7.49
- Average True Range (ATR)
- NVAX 0.57
- JBLU 0.37
- MACD
- NVAX -0.12
- JBLU -0.18
- Stochastic Oscillator
- NVAX 9.97
- JBLU 0.46
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.